Events

Oct 2025

• Tue 21

  • 12:15 pm - 1:15 pm PDT

    The Many Faces of Type 2 Inflammation: Unraveling Its Role Across Dermatologic Conditions and a Treatment Option for Appropriate Patients.
    by Linda Stein Gold, MD

  • 12:15 pm - 1:15 pm CDT

    The Shades of Atopic Dermatitis in Skin of Color and a Treatment Option for Appropriate Patients with Type 2 Inflammation
    by Fred Ghali, MD

• Wed 22

  • 12:15 pm - 12:45 pm EDT

    A Treatment Option for Appropriate Patients with Certain Skin Diseases Driven in Part by Type 2 Inflammation
    by Eileen Cheever, PA-C

  • 12:15 pm - 1:15 pm PDT

    DUPIXENT^@ (dupilumab) Patient Story followed by A Treatment Option for Appropriate Patients with Certain Skin Diseases Driven in Part by Type 2 Inflammation
    by Zakiya Rice, MD

• Thu 23

  • 12:15 pm - 1:15 pm CDT

    Clinical Case Discussion: An Adult Patient with Uncontrolled Moderate-to-Severe Atopic Dermatitis and a Treatment Option for Appropriate Patients 6+ Months of Age
    by Marshall Shuler, MD

• Mon 27

  • 12:15 pm - 1:15 pm CDT

    Pearls and Common Challenges for the Diagnosis of Bullous Pemphigoid (BP)
    by Timothy Patton, DO

• Tue 28

  • 12:15 pm - 1:15 pm EDT

    DUPIXENT^®(dupilumab) Patient Story followed by A Treatment Option for Appropriate Patients with Certain Skin Diseases Driven in Part by Type 2 Inflammation
    by Roopen Patel, MD

• Wed 29

  • 12:15 pm - 12:45 pm EDT

    A Treatment Option for Appropriate Patients with Certain Skin Diseases Driven in Part by Type 2 Inflammation
    by Douglas DiRuggiero, PA-C

  • 12:15 pm - 1:15 pm PDT

    Beneath the Itch: The Role of Type 2 Inflammation and a Treatment Option for Appropriate Patients with Certain Skin Diseases Driven in Part by Type 2 Inflammation
    by Ben Ehst, MD

• Thu 30

  • 12:15 pm - 1:15 pm EDT

    A Treatment Option for Appropriate Patients with Certain Skin Diseases Driven in Part by Type 2 Inflammation
    by Marc Serota, MD